About Crinetics Pharma
Crinetics Pharmaceuticals, Inc. is a United States-based therapeutics company. The Company is focused on discovery, development, and commercialization of oral nonpeptide therapeutics for endocrine diseases and endocrine-related tumors. It uses a pipeline of oral nonpeptide (small molecule) new chemical entities that targets peptide G protein coupled receptors (GPCRs) to treat a variety of endocrine diseases. The Company's product range includes CRN00808, for the treatment of acromegaly; CRN02481, for the treatment of hyperinsulinemias; CRN01941, for the treatment of neuroendocrine tumors (NETs).